Allergy Therapeutics
AGY.L
#9575
Rank
NZ$0.22 B
Marketcap
NZ$0.03486
Share price
3.57%
Change (1 day)
-83.61%
Change (1 year)

Earnings for Allergy Therapeutics (AGY.L)

Earnings in 2025: -NZ$96.67 Million

According to Allergy Therapeutics's latest financial reports the company's current earnings are NZ$75.57 Million. In 2025 the company made an earning of -NZ$96.67 Million a decrease over its 2024 earnings that were of -NZ$88.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Allergy Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025-NZ$96.67 Million8.65%
2024-NZ$88.97 Million-6.69%
2023-NZ$95.36 Million244.94%
2022-NZ$27.65 Million-404.35%
2021NZ$9.08 M-49.42%
2020NZ$17.95 M83.48%
2019NZ$9.78 M-159.83%
2018-NZ$16.36 Million255.48%
2017-NZ$4.61 Million-84.06%
2016-NZ$28.88 Million-1667.33%
2015NZ$1.84 M-44.68%
2014NZ$3.33 M130.59%
2013NZ$1.44 M-19.89%
2012NZ$1.8 M-127.05%
2011-NZ$6.67 Million2009.96%
2010-NZ$0.32 Million-99.07%
2009-NZ$33.85 Million-53.23%
2008-NZ$72.37 Million-21.86%
2007-NZ$92.62 Million356.94%
2006-NZ$20.27 Million230.75%
2005-NZ$6.13 Million-217.9%
2004NZ$5.19 M-58.79%
2003NZ$12.61 M-196.03%
2002-NZ$13.14 Million